Search

Your search keyword '"Jood, K."' showing total 398 results

Search Constraints

Start Over You searched for: Author "Jood, K." Remove constraint Author: "Jood, K."
Sorry, I don't understand your search. ×
398 results on '"Jood, K."'

Search Results

1. Association between multimorbidity and cognitive decline in the elderly population of the Eastern Province, Saudi Arabia

2. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

3. Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆

4. Outcomes after reperfusion therapies in patients with ACA stroke: A multicenter cohort study from the EVATRISP collaboration

7. Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19

8. Oncocytic lipoadenoma of the parotid gland: a case report and a review of the literature.

11. Pediatric intranasal lobular capillary hemangioma: a case report and review of the literature.

12. S100b in acute ischemic stroke clots is a biomarker for post-thrombectomy intracranial hemorrhages

13. Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19

14. Age of onset of cerebral venous thrombosis: the BEAST study

15. The relevance of rich club regions for functional outcome post-stroke is enhanced in women.

16. Decompressive surgery in cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia.

17. Direct oral anticoagulants for the treatment of cerebral venous thrombosis - a protocol of an international phase IV study.

18. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19.

19. Radiomics-Derived Brain Age Predicts Functional Outcome After Acute Ischemic Stroke.

20. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial

23. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

24. Sex-specific lesion pattern of functional outcomes after stroke.

25. Deep profiling of multiple ischemic lesions in a large, multi-center cohort: Frequency, spatial distribution, and associations to clinical characteristics.

26. Age-Stratified Risk of Cerebral Venous Sinus Thrombosis After SARS-CoV-2 Vaccination

27. Global Differences in Risk Factors, Etiology, and Outcome of Ischemic Stroke in Young Adults-A Worldwide Meta-analysis: The GOAL Initiative

28. Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination

29. Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

30. Outcomes of Cerebral Venous Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia After the Acute Phase

31. Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 Vaccination

32. Association of Stroke Lesion Pattern and White Matter Hyperintensity Burden With Stroke Severity and Outcome.

33. Stroke genetics informs drug discovery and risk prediction across ancestries

34. L’âge cérébral radiomique prédit le pronostic fonctionnel après un avc ischémique.

36. Outcomes after reperfusion therapies in patients with ACA stroke: A multicenter cohort study from the EVATRISP collaboration

39. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

40. Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry

41. Large Artery Atherosclerotic Clots are Larger than Clots of other Stroke Etiologies and have Poorer Recanalization rates

42. EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: Basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry

43. Excessive White Matter Hyperintensity Increases Susceptibility to Poor Functional Outcomes After Acute Ischemic Stroke.

44. Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 Pandemic

45. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

46. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency

47. MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes

48. Genome-Wide Association Study Identifies First Locus Associated with Susceptibility to Cerebral Venous Thrombosis

49. Outcome after acute ischemic stroke is linked to sex-specific lesion patterns

50. Prediction of a time-sensitive condition among patients with dizziness assessed by the emergency medical services

Catalog

Books, media, physical & digital resources